Community Based Doulas for Migrant Women in Labour and Birth in Sweden - a Randomised Controlled Trial

October 29, 2020 updated by: Erica Schytt, Karolinska Institutet

One initiative to address communication problems between migrant women not fluent in Swedish and caregivers throughout childbirth is to provide language assistance, cultural interpretation and labour support to the woman through Community Based Doulas (CBDs). CBDs are bilingual women from migrant communities trained by midwives to provide cultural, language and labour support to migrant women throughout their labour and birth.

The study will evaluate the effectiveness of community-based doula support for improving the intrapartum care experiences and postnatal wellbeing of Somali-, Tigrinya -, Arabic- and Russian-speaking migrant women giving birth in Stockholm, Sweden.

The randomisation ratio will be 1:1; CBD support in addition to standard intrapartum care or standard intrapartum care. Women allocated to receive CBD support in addition to standard intrapartum care (intervention group), will be contacted by a Somali, Arabic-, Russian- or Tigrinya-speaking CBD as appropriate, and arrangements will be made for the doula and the women to meet twice prior to the birth to get to know each other and discuss the woman's wishes regarding support in labour and what the CBD can offer. Each woman will then contact her CBD when she goes into labour and the CBD will attend hospital with her and stay with her throughout labour and birth, in addition to any other support people she may have, such as her partner. Women allocated to the comparison arm of the trial will receive standard intrapartum care as provided at their chosen hospital of birth.

The hypothesis is that women randomised to receive CBD support in labour will rate their care for labour and birth more highly and have better emotional wellbeing (lower mean scores on the Edinburgh Postnatal Depression Scale) two months after birth than women allocated to standard care.

Study Overview

Detailed Description

In Sweden, the proportion of births to migrant women has more than doubled over the last four decades, from 10% in 1973 to 28% in 2015. Migrant women are at increased risk of adverse pregnancy outcomes as low birth weight, infant small for gestational age , congenital malformations, stillbirth, neonatal morbidity and mortality and also obstetric interventions, such as induction of labour and caesarean section. Unfamiliarity with the health care system, language barriers, knowledge gaps and cultural issues are all obstacles that play a vital role in migrant women deprivation from achieving the standard maternal health care.

Migrant women have shown to consistently rate their maternity care more negatively in contrast with Swedish women, mainly due to lack of knowledge on how Swedish health care system is functioning and providing care which consequently cause communication difficulties, in addition to discrimination and prejudicial staff attitudes. Migrant women reported being left alone in labour, and feeling fearful, insecure and unsupported. Factors to be targeted to improve experiences of care and pregnancy outcomes include; breaking down language barriers and bridging cultural gaps, increasing familiarity with and enhancing understanding of Swedish maternity care, and empowering women's sense of safety and confidence in giving birth.

In Sweden, migration of women of childbearing age has increased most rapidly from Somalia and from a number of Arabic-speaking countries and also Eritrea and Russia. Somali women are known to be at highest risk of perinatal morbidity and mortality, they have problems engaging with Swedish antenatal care and because of communication and language barriers they reported to have the poorer experiences of care regarding labour and birth. Like Somali-women, many Arabic-speaking and Tigrinya-speaking women (from Eritrea) have relocated in Sweden after traumatic experiences of war and conflict. They, and the Russian women, constitute a growing group of women giving birth in Sweden with little knowledge of how Swedish maternity care operates and facing major communication barriers.

One initiative that has addressed communication problems between migrant women and the caregivers throughout childbirth was to provide language assistance and labour support , the Community Based Doula (Doula och kulturtolk) Project. CBDs are bilingual women from migrant communities trained by expert midwives to provide support for migrant women in labour and birth. CBDs meet twice with the migrant women prior to the birth, accompany her throughout the labour and provide emotional, physical support and communication; and language assistance; they meet again for follow up twice after the childbirth. Two small qualitative evaluations, conducted in the early years of the program, indicate high levels of satisfaction among supported women and midwives.

Current evidence supports the potential for CBDs to play an important role in improving continuity for migrant women during labour and birth, enhancing their experiences of birth and of care, as improving their pregnancy outcomes. Good physical and emotional support in labour is known to improve a range of outcomes; greater maternal satisfaction with care, less use of analgesia, shorter labours, lower rates of caesarean section and more spontaneous vaginal birth - with no adverse effects for women or infants.

Worldwide, no randomised controlled trials of doula support for migrant women have been reported, though two US non-randomised studies are relevant. One evaluated a hospital-based doula service provided to 123 of 348 Somali women giving birth in the study period. Lower rates of caesarean section (17% vs 26%) and greater satisfaction with care were found among the doula-supported Somali women17. Staff also felt more confident to care for Somali women when an English-speaking Somali doula was present. A second retrospective cohort study (n=11 471) evaluated a community doula program in an urban, culturally diverse setting and found a small but statistically significant reduction in caesarean section among women cared for by a midwife and a doula, compared with a midwife alone (15% vs 18%)18. Studies of midwives' views of working alongside labour companions have been positive14, 18.

In the Swedish setting, more robust and specific evidence is needed to support decisions whether to implement CBDs for migrant women at large-scale or not. Therefore, to evaluate the effectiveness of doula support to Somali, Eritrean, Arabic and Russian-speaking migrants we will here conduct a randomized controlled trial in Stockholm.

Aim To evaluate the effectiveness of community-based doula support for improving the intrapartum care experiences and postnatal wellbeing of Somali, Eritrean, Arabic and Russian-speaking migrant women giving birth in Stockholm.

Hypotheses

  1. That women randomised to receive CBD support in labour will rate their care for labour and birth more highly and have better emotional wellbeing (lower mean scores on the Edinburgh Postnatal Depression Scale) two months after birth than women allocated to standard care.
  2. That midwives and obstetricians caring for women randomised to receive CBD support will rate their provision of care more positively than when caring for women not supported.

Methods We plan a randomised controlled trial as a prospective evaluation of CBD support for migrant women in Stockholm, something not achieved when the original CBD program commenced in Gothenburg in 2008. The proposed trial will provide further and more rigorous evidence about the effectiveness of CBDs for improving migrant women's experiences of care and ultimately pregnancy outcomes for both mothers and infants. The study is designed to meet the CONSORT guidelines for reporting of randomised trials16 and will be registered in Clinical Trials.

Participants Migrant women from Somali, Tigrinya, Arabic and Russian-speaking countries will be recruited.

Inclusion criteria: Nulliparous and multiparous pregnant women between 25-36 weeks gestation, who are 18 years or older and from Somali-, Arabic-, Russian- and Tigrinya-speaking countries with no contra-indications for vaginal birth and cannot communicate fluently in Swedish.

Exclusion criteria: Women <18 years or women for whom a caesarean birth is planned and women not consenting to access to their birth records.

Recruitment: All Somali-, Arabic-, Russian and Tigrinya-speaking women cover the inclusion criteria and will participate in the study. They will be recruited with the assistance of interpreters during antenatal care visits between 25 and 36 weeks gestation.

Intervention - Community Based Doulas support Women allocated to receive CBD support will be contacted by an either a Somali, Arabic-, Russian- or Tigrinya-speaking CBD as appropriate, and arrangements made for them to meet twice prior to the birth to get to know each other and discuss the woman's wishes regarding support in labour and what the CBD can offer. Each woman will then contact her CBD when she goes into labour and the CBD will attend hospital with her and stay with her throughout her labour and birth, in addition to any other support people she may have, such as her partner.

CBDs will be recruited, trained and employed by non-profit organization MIRA, using well-tested processes. A total of 10 CBDs will be employed for the four migrant groups, ensuring the possibility of back-up when needed. Training content will cover the physiology of childbirth and strategies for providing effective continuous support in labour, as well as practical strategies for helping with communication/interpreting to enhance communication between women and midwives and discussion of CBD roles and boundaries. CBDs will be employed on an hourly basis to enable flexibility in timely provision of support to women in labour. Support for CBDs will be provided by an experienced midwife.

Comparison - standard intrapartum care Women allocated to the comparison arm of the trial will receive standard intrapartum care as provided at their chosen hospital of birth.

Women partner and/or other support people to accompany throughout her childbirth will be allowed, regardless of their trial allocation.

Randomisation and blinding Women will be randomly allocated to the intervention or control group utilising a computerised randomisation schedule. The randomisation ratio will be 1:1, CBD support to usual care, with block sizes of 4 or 6 distributed randomly. Allocations will be prepared in sealed, opaque envelopes accessible in a central location for antenatal recruiting midwives to access. Participants cannot be blinded in this study, however data collection and analysis will be undertaken blinded to group allocation.

Primary outcomes Women's ratings of care for labour and birth and maternal emotional wellbeing. Single item question from the Migrant Friendly Maternity Care Questionnaire (MFMCQ) will be used to assess women's ratings of care the Edinburgh Postnatal Depression Scale (the EPDS) will be used to assess maternal wellbeing.

Secondary outcomes Epidural analgesia, length of labour from admission and mode of birth. Data will be retrieved from hospital patient records will enable assessment of birth outcomes.

Data collection Trained bilingual researcher and research assistants will collect data on women's experiences of care by telephone or face-to-face interviews as appropriate, conducted at base-line and two months after birth. Birth outcome data for all trial participants will be extracted from patient records.

Sample size To detect an increase in women's ratings of intrapartum care from an expected 30% rating care as very good among those receiving usual care (based on estimates from studies of migrant women not fluent in the host country language) 22-24 to 53% in those receiving CBD support, (equal to Swedish speaking women in a national population based study) with 80% power and an alpha of 20%, 69 women in each group are needed. To have similar power to detect differences in mean scores on the Edinburgh Postnatal Depression Scale (a hypothesised reduction from a mean of 8.0 in the comparison group - similar to that found in studies of migrant women, to 6.0 in the intervention group - similar to that found in Swedish population-based studies), 63 women are required in each arm. Allowing for 20% loss to follow-up at the time of follow-up data collection with women two months postpartum, we expect to have outcome data on views of care and depressive symptoms for at least 100 women in each trial arm.

Statistical analysis First step of analysis will check the comparability of the groups, then the intervention group will be compared with the control group testing trial hypotheses and using intention to treat analyses. Odds ratios and 95% confidence intervals will then be estimated. If there are baseline differences on key participant characteristics (such as age, marital status, and medical conditions) between trial arms, logistic regression analyses will be performed adjusting for these differences. Comparison of means will be undertaken using t-tests where data are normally distributed, or medians compared using Mann-Whitney U tests used if not.

Study Type

Interventional

Enrollment (Actual)

164

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Stockholm, Sweden
        • Erica Schytt

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Nulliparous and multiparous pregnant women
  • 25-36 weeks gestation
  • Somali-, Arabic-, Russian- or Tigrinya-speaking
  • Cannot communicate fluently in Swedish
  • No contra-indications for vaginal birth

Exclusion Criteria:

  • Planned caesarean birth
  • Not consenting to access to their birth records
  • 17 years old or younger

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Community-based doula support for labour

Women will receive support from a Community-based doula (CBD) plus standard labour support. Women will meet twice with the CBD prior to the birth to get to know each other and discuss the woman's wishes regarding support in labour and what the CBD can offer. The CBD will then stay with her throughout her labour and birth and support her with interpretation/Communication with the staff and emotional and instrumental support. The CBD-support will be in addition to any other support people she may have, such as her partner.

Note: Women partner and/or other support people to accompany throughout her childbirth will be allowed, regardless of their trial allocation.

CBDs will be recruited, trained and employed by non-profit organization MIRA, using well-tested processes.

CBDs will be recruited, trained and employed by non-profit organization MIRA. Women allocated to receive CBD support will be contacted by an either a Somali, Arabic-, Russian- or Tigrinya-speaking CBD as appropriate, and arrangements made for them to meet twice prior to the birth to get to know each other and discuss the woman's wishes regarding support in labour and what the CBD can offer. Each woman will then contact her CBD when she goes into labour and the CBD will attend hospital with her and stay with her throughout her labour and birth, in addition to any other support people she may have, such as her partner.

Standard labour support by health care providers only. Women allocated to the comparison arm of the trial will receive standard intrapartum care as provided at their chosen hospital of birth. That is emotional, information and instrumental support from a helping nurse or a midwife or in some cases a doctor. The support includes caring actions, such as comforting, massage, information and presence.

Note: Women partner and/or other support people to accompany throughout her childbirth will be allowed, regardless of their trial allocation.

Active Comparator: Standard labour support

Standard labour support by health care providers only. Women allocated to the comparison arm of the trial will receive standard intrapartum care as provided at their chosen hospital of birth. That is emotional, information and instrumental support from a helping nurse or a midwife or in some cases a doctor. The support includes caring actions, such as comforting, massage, information and presence.

Note: Women partner and/or other support people to accompany throughout her childbirth will be allowed, regardless of their trial allocation.

CBDs will be recruited, trained and employed by non-profit organization MIRA. Women allocated to receive CBD support will be contacted by an either a Somali, Arabic-, Russian- or Tigrinya-speaking CBD as appropriate, and arrangements made for them to meet twice prior to the birth to get to know each other and discuss the woman's wishes regarding support in labour and what the CBD can offer. Each woman will then contact her CBD when she goes into labour and the CBD will attend hospital with her and stay with her throughout her labour and birth, in addition to any other support people she may have, such as her partner.

Standard labour support by health care providers only. Women allocated to the comparison arm of the trial will receive standard intrapartum care as provided at their chosen hospital of birth. That is emotional, information and instrumental support from a helping nurse or a midwife or in some cases a doctor. The support includes caring actions, such as comforting, massage, information and presence.

Note: Women partner and/or other support people to accompany throughout her childbirth will be allowed, regardless of their trial allocation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maternal wellbeing
Time Frame: 6-8 weeks post partum
Maternal wellbeing as measured with the Edinburgh Postnatal Depression Scale (EPDS) (comparisons of mean values)
6-8 weeks post partum
Women's overall ratings of labour care
Time Frame: 6-8 weeks post partum
Single item question:In general, were you happy with the healthcare you received? Very happy to No, not so happy.
6-8 weeks post partum

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Experience of birth
Time Frame: 6-8 weeks postpartum
Single-item question measuring experience of giving birth on a five point scale
6-8 weeks postpartum
Epidural analgesia
Time Frame: Immediately after the birth
prospectively collected data during labour
Immediately after the birth
Length of labour
Time Frame: Immediately after the birth
From admission to birth of the baby
Immediately after the birth
Mode of birth
Time Frame: Immediately after the birth
Spontanous vaginal, instrumental vaginal or cesarean section
Immediately after the birth
Apgar score
Time Frame: 5 minutes after the birth
5 items (Skin color, pulse rate, reflex irritability grimace, activity, respiratory effort) using a 0-2 scale for assessment of infant Health with total sum 10 wich is perfect
5 minutes after the birth
Satisfaction with labour support
Time Frame: 6-8 weeks postpartum
Overall, what do you think about all the support you received during childbirth? Very happy to Not so happy (5-response scale)
6-8 weeks postpartum
Overall birth experience
Time Frame: 6-8 weeks postpartum
Single item: What was your overall experience of giving birth? From very positive to very negative
6-8 weeks postpartum
Neonatal intensive care
Time Frame: Within 7 days after birth
Transfer to NICO according to patient record
Within 7 days after birth

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Erica Schytt, Professor, Karolinska Institutet

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 10, 2018

Primary Completion (Actual)

May 5, 2020

Study Completion (Actual)

May 5, 2020

Study Registration Dates

First Submitted

February 23, 2018

First Submitted That Met QC Criteria

March 5, 2018

First Posted (Actual)

March 12, 2018

Study Record Updates

Last Update Posted (Actual)

November 2, 2020

Last Update Submitted That Met QC Criteria

October 29, 2020

Last Verified

October 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • K63135016

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

Not included in the ethical approval

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Labor Pain

Clinical Trials on Community-based doula support for labour

3
Subscribe